Kristian (Krist) Werling represents private equity and strategic investors in a wide variety of transactional matters in the healthcare and life sciences industry. In this capacity, he works with cross-disciplinary teams to conduct legal due diligence and execute acquisitions and divestitures, as well as provide ongoing legal services to portfolio companies. Clients look to Krist for his ability to lead teams of lawyers that develop creative transaction structures that enable deals to close. In the healthcare services arena, Krist has particular experience with transactions and joint ventures involving physician practice management, ambulatory surgical centers, specialty hospitals, dermatology, pain management and anesthesia physician practices and dental practice management companies.

Mehr anzeigen

Ausgewählte Referenzmandate

  • Windrose Health Investors in the acquisition and sale of Celerion and Medical Knowledge Group as well as its investments in Trumpet Behavioral Health and Lykan Biosciences
  • Baxter International in a wide variety of transactions including the acquisition of a portfolio of hemostasis product lines from Mallinckrodt, multiple undisclosed acquisitions of liquid injectable pharmaceutical products, the acquisition of Chatham Therapeutics and strategic licenses with ScinoPharm Taiwan and Merrimack Pharmaceuticals
  • Ampersand Capital Partners in the acquisition of New England Peptides, Peptides International, Canopy Biosciences, Zellwerkraft, Adaptas/ETP Ion Detect and Applied Kilovolts, Genome Diagnostics and Sanova Dermatology

Mehr anzeigen


  • The Legal 500 US 2017 and 2019
  • LMG Life Sciences, Life Sciences Star, 2016, 2018, 2019
  • LMG Life Sciences’ 2015 “Collaboration Deal of the Year,” for representation of Baxalta in a global license and collaboration with Merrimack Pharmaceuticals
  • The M&A Advisor, Top 40 Under 40 Legal Advisors 2015


  • North Park University Board of Trustees
  • American Health Lawyers Association, former chair of the Life Science Practice Group, and editor in chief of the second edition of The Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech


Northwestern University J.L. Kellogg School of Management, MBA, 2010
University of Illinois College of Law, JD, magna cum laude, 2002
North Park University Chicago, BA, cum laude, 1999


Kristian A. Werling

Einblicke & Events / Medien

Munich, Germany / McDermott Event / September 25, 2018

Cambridge, Massachusetts / McDermott Event / September 12, 2018

Cambridge, Massachusetts / McDermott Event / October 4, 2017

Paris, France / McDermott Event / May 23, 2017

Chicago, Illinois / McDermott Event / May 4, 2017

San Francisco, California / McDermott Event / January 10, 2017